[Clinical studies on flomoxef in pregnant women with infections during the perinatal period].
Clinical efficacies of flomoxef (FMOX), which is a newly developed oxacephem antibiotic, were evaluated in 14 cases of obstetric and gynecologic infections during the perinatal period. The results were excellent in 6 cases (42.9%) and good in 8 cases (57.1%). No side effects nor abnormal clinical laboratory test results were observed in mothers or neonates. Thus, FMOX appears to be a useful antibiotic for perinatal infections.
Iwaki
M
M
Department of Obstetrics and Gynecology, Hokkaido University School of Medicine.
Makinoda
S
S
Negishi
H
H
Hanatani
K
K
Tanaka
T
T
Fujimoto
S
S
D000328:Adult; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D002821:Chorioamnionitis / Q000188:drug therapy; D004341:Drug Evaluation; D004716:Endometritis / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000382:microbiology; D011645:Puerperal Infection / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D002511:Cephalosporins; C045693:flomoxef